Pharmacokinetics and Bioavailability
Dermax supports clinical research focused on the pharmacokinetic behavior of valacyclovir formulations in healthy subjects, with attention to oral suspension and tablet comparators.
- Bioavailability assessment in healthy volunteers
- Comparative formulation performance
- Food effect evaluation
Its trial portfolio is centered on oral antiviral formulation studies designed to characterize absorption and exposure profiles under controlled conditions.
Antiviral Oral Formulations
The sponsor’s research interest includes valacyclovir as an antiviral therapy, with studies comparing suspension and tablet presentations used in routine clinical development.
- Valacyclovir formulation comparison
- Oral suspension development
- Tablet reference products
These activities reflect a focus on optimizing oral delivery options for established antiviral treatment.
Healthy Volunteer Studies
Dermax conducts studies in normal, healthy subjects to evaluate tolerability and exposure characteristics without disease-specific enrollment.
- Healthy subject enrollment
- Safety profile monitoring
- Controlled crossover comparisons
The sponsor’s active trial work is concentrated in a single country, with all listed studies currently recruiting in Belgium.
Comparative Pharmaceutical Development
The clinical research landscape includes direct comparisons with established reference products, supporting development of alternative valacyclovir formulations.
- Reference product comparison
- Extemporaneous suspension benchmarking
- European-sourced tablet comparison
Dermax’s funded studies are aligned with pharmaceutical development interests in formulation equivalence and oral product characterization.
